Rhythm Pharmaceuticals, Inc.

RYTM · Healthcare

$104.74

Capitalizzazione: 7.21B USDRendimento da dividendo: —
AdvanceÈ un buon momento per comprare Rhythm Pharmaceuticals, Inc.? Chiedi a Copenvest AIOttieni un'analisi Advance con AI su timing, rischio e cosa fanno gli investitori tracciati.Chiedi a Copenvest AI

Caricamento grafico…

Notizie

Ultime notizie su questo titolo

BioPharma Dive3 set 2026, 12:20

An AI drug specialist zeroes in on rare forms of obesity

The Fly28 ago 2026, 13:38

Moderna upgraded, Allstate downgraded: Wall Street's top analyst calls

24/7 Wall St.28 ago 2026, 11:50

Here Are Friday’s Top Wall Street Analyst Research Calls: Baozun, Commerce Bancshares, Element Solutions, Evolution Petroleum, Petrobras, Rythm Pharmaceuticals, Terawulf, UMB Financial, Workday, and More

MT Newswires28 ago 2026, 11:26

Deutsche Bank Initiates Rhythm Pharmaceuticals at Hold With $120 Price Target

Simply Wall St.26 ago 2026, 10:15

Rhythm Pharmaceuticals (RYTM) Stock Looks Overvalued Despite Its 7x Five Year Run